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ABSTRACT 
 
Protein degradation, by means of ubiquitylation tagging for subsequent degradation by the 
ubiquitin-proteasome system (UPS), has opened up a newfound way of protein degradation 
some three to four decades back. Termed the ‘kiss of death’, this field of study has since 
sparked off the quest for substrates for the main enzymes executing ubiquitylation, the E3 
ligases. Ubiquitylation of proteins have been implicated in a wide variety of biological 
processes, many of which whose dysregulation lead to tumorigenesis. One major subgroup, the 
SCF-type of E3 ligases, utilizes a variable component, an F-box protein, for substrate 
recognition. However, with more than 70 F-box proteins in our genome, most of them poorly 
characterized, it remains a challenge to unravel the biological significance of each of these 
proteins. In this thesis, we seek to expand the understanding of two of such SCF-type E3 
ligases, namely, Fbw7 and FBXO28 and their substrates in processes such as cyclin E 
regulation by Fbw7, MYC-mediated transcription and tumorigenesis by FBXO28 and cell 
motility with the focus on ßPIX as a substrate of FBXO28. 
Previous work has demonstrated that the SCF(Fbw7/Cdc4) complex is responsible for the 
ubiquitin-dependent degradation of cyclin E1. In the first study (Paper I), we show that a 
cooperation between Fbw7! and Fbw7" is required for driving ubiquitylation and degradation 
of cyclin E1 in the nucleolus. Specifically, we show that Fbw7! acts as a cofactor for Pin1 and 
aids in isomerization of the cyclin E1 phosphodegron and subsequent translocation and 
targeting of cyclin E1 for degradation in the nucleolus by Fbw7".  
In the two other studies, we investigate the function of FBXO28. In Paper II, we identify a 
previously uncharacterized cell cycle-regulated F-box protein, FBXO28, and explore its role in 
cancer. We show that the CDK1/2 phosphorylated FBXO28 protein assembles a SCFFBXO28 
ubiquitin ligase that targets MYC for non-proteolytic ubiquitylation and demonstrate that this is 
important for MYC-driven transcriptional activity. Furthermore, expression of a non-functional 
FBXO28 mutant or silencing FBXO28 leads to impairment in MYC-driven transcriptional 
activity, transformation and tumorgenesis. Lastly, we show that high FBXO28 expression and 
phosphorylation are indicators for poor prognosis in breast cancer. In Paper III we find that 
FBXO28 is able to interact with a group of proteins, the PAK1-ßPIX-GIT1 complex, that are 
key players in cell migration. FBXO28 is found to localize to the cell-matrix complex upon 
treatment with EGF and ubiquitylates ßPIX in a non-proteolytic but phosphorylation-dependent 
manner. Additionally, we show that FBXO28 positively regulates the formation of PAK1-
ßPIX-GIT1 complexes, and a depletion of FBXO28 leads to an impairment in cell migration 
and invasion of metastatic cancer cells. Furthermore, we demonstrate a poor prognosis for 
breast cancer patients with membranous staining of FBXO28. 
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